Spotlighting Emergent CAR T-Cell Therapy in High-Risk B-Cell Lymphomas
Written by
Cancer Network
Published
0
comments
0
min
Jose Sandoval Sus, MD, discussed standard CAR T-cell therapies in patients across multiple high-risk lymphoma indications.